Effect of an Albumin Infusion Treatment Protocol on Delayed Cerebral Ischemia and Relevant Outcomes in Patients with Subarachnoid Hemorrhage

[1]  Y. Temel,et al.  The Role of the Glycocalyx in the Pathophysiology of Subarachnoid Hemorrhage-Induced Delayed Cerebral Ischemia , 2021, Frontiers in Cell and Developmental Biology.

[2]  X. Nuvials,et al.  Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review , 2020, Annals of Intensive Care.

[3]  H. Steiger,et al.  An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage , 2018, Neurosurgical Review.

[4]  R. Geocadin,et al.  Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations , 2018, Intensive Care Medicine.

[5]  A. Baker,et al.  Biomarkers of Glycocalyx Injury are Associated with Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Case Series Supporting a New Hypothesis , 2017, Neurocritical Care.

[6]  Xinfeng Liu,et al.  Preclinical efficacy of human Albumin in subarachnoid hemorrhage , 2017, Neuroscience.

[7]  P. Austin,et al.  Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement , 2017, Statistics in medicine.

[8]  M. Jacob,et al.  Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases , 2015, British journal of clinical pharmacology.

[9]  M. Vogeser,et al.  Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx , 2014, Critical Care.

[10]  R. Macdonald,et al.  The Effects of Fluid Balance and Colloid Administration on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage: A Propensity Score-Matched Analysis , 2013, Neurocritical Care.

[11]  Michael Forsting,et al.  European Stroke Organization Guidelines for the Management of Intracranial Aneurysms and Subarachnoid Haemorrhage , 2013, Cerebrovascular Diseases.

[12]  K. Pattinson,et al.  Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. , 2012, British journal of anaesthesia.

[13]  Giuseppe Citerio,et al.  Critical Care Management of Patients Following Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference , 2011, Neurocritical care.

[14]  F. Aversa,et al.  Regression modeling of competing risk using R: an in depth guide for clinicians , 2010, Bone Marrow Transplantation.

[15]  D. Longrois,et al.  Endocrine Response After Severe Subarachnoid Hemorrhage Related to Sodium and Blood Volume Regulation , 2009, Anesthesia and analgesia.

[16]  Zoran Bursac,et al.  Purposeful selection of variables in logistic regression , 2008, Source Code for Biology and Medicine.

[17]  F. Aversa,et al.  Competing risk analysis using R: an easy guide for clinicians , 2007, Bone Marrow Transplantation.

[18]  J. Suarez,et al.  Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. , 2004, Journal of neurosurgery.

[19]  S. Mayer,et al.  Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage. , 1998, Neurosurgery.

[20]  Pam Wybrant,et al.  Assessment and record keeping , 1997 .

[21]  D. Kleinbaum,et al.  Applied Regression Analysis and Other Multivariate Methods , 1978 .

[22]  R. Macdonald,et al.  Delayed neurological deterioration after subarachnoid haemorrhage , 2014, Nature Reviews Neurology.

[23]  D. Zygun,et al.  Human Albumin Administration in Subarachnoid Hemorrhage: Results of an International Survey , 2013, Neurocritical Care.

[24]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .